Improvement of B Cell Responses by an HIV-1 Amphiphilic Polymer Nanovaccine

Improvement of B Cell Responses by an HIV-1 Amphiphilic Polymer Nanovaccine

The human immunodeficiency virus (HIV) has infected over 84 million people since its discovery and is a huge threat to human health. While an HIV vaccine is urgently needed to curb this devastating pandemic, it has been notoriously difficult to develop, partly due to the extraordinary high level of...

Full description

Bibliographic Details
Main Authors: Chang, Y. (Author), Gao, F. (Author), Guo, L. (Author), Liu, X. (Author), Liu, Y. (Author), Lu, D. (Author), Shan, Y. (Author), Wan, M. (Author), Wang, H. (Author), Xin, X. (Author), Zhang, Q. (Author), Zhang, Y. (Author)
Format: Article
Language:English
Published: American Chemical Society 2023
Subjects:
amphiphilic polymers
Amphiphilic polymers
B cells
Cell response
Diseases
envelope glycoprotein
Envelope glycoproteins
Genes
Genetic variation
Glycoproteins
Health risks
HIV-1
Human health
Human immunodeficiency virus
Human immunodeficiency virus-1
nanovaccine
Nanovaccine
Neutralisation
neutralization
stability
Vaccines
Viruses
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items